Write For Us

Pharmaceutical giant slashes insulin prices after pressure from government and consumers

Sponsored Post Vitamin D2 Canada Persia
36 Views
Published
More than seven million Americans rely on insulin and prices for the life-saving drug have sky-rocketed. With pressure mounting on pharmaceutical companies to address the cost of diabetes care, Eli Lilly announced it’s cutting prices for its most popular insulin products by 70% and capping out-of-pocket costs at $35 a month. Bram Sable-Smith of Kaiser Health News joined Geoff Bennett to discuss.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
TikTok: https://www.tiktok.com/@pbsnews
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Facebook: http://www.pbs.org/newshour

Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
Category
U.S. & Canada
Sign in or sign up to post comments.
Be the first to comment